NCT01442818

Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery

Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery: A Randomized Trial Comparing Patient-Controlled Intravenous Analgesia (PCA) to Scheduled Intravenous Analgesia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: TriHealth Inc. · Academic / Other
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery.

Detailed description

The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery. In order to determine if there is a significant correlation, secondary outcomes will include the daily and total narcotic volume used, common side effects from the opioid including nausea, vomiting, or pruritis, length of hospital stay, timing of flatus and first bowel movement, all complications, and procedure performed.

Conditions

• Post Operative Pain

Interventions

Type	Name	Description
DRUG	Dilaudid PCA	PCA setting of 0.3mg demand dose, 8 minute lock out interval, and 5mg 4-hour limit.
DRUG	Dilaudid IV Scheduled	Nurse administered IV Dilaudid 0.5mg every 2 hours.

Timeline

• Start date: 2010-09-01
• Primary completion: 2011-09-01
• Completion: 2012-10-01
• First posted: 2011-09-29
• Last updated: 2015-07-10

Locations

1 site across 1 country: United States